Éric Delaporte médecin, universitaire
Delaporte, Éric, 1956-..., microbiologiste
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 173749319 (Personal)
Permalink: http://viaf.org/viaf/173749319
Preferred Forms
4xx's: Alternate Name Forms (5)
Works
| Title | Sources |
|---|---|
| Accès à la charge virale pour les patients infectés par le VIH sous traitement antiretroviral, en zone décentralisée des pays à niveau de ressources faible ou modéré |
|
| Accès au traitement antirétroviral en Afrique : le cas du Cameroun |
|
| Access to viral load monitoring for HIV infected patients on Antiretroviral Treatment in Decentralised area of low and middle income countries. |
|
| Attitude et connaissances des médecins généralistes de l'Hérault concernant le paludisme d'importation en 2008 |
|
| Care of people living with the human immunodeficiency virus in decentralized areas in Cameroon. |
|
| Contribution à l'étude des questions statistiques rencontrées dans l'analyse des données de cohorte de personnes vivant avec le VIH sous traitement antirétroviral dans un contexte de ressources limitées |
|
| Contribution to the study of statistical issues encountered in the analysis cohort of people living with HIV receiving antiretroviral therapy in resource-limited settings. |
|
| Diversité génétique du VIH-1 : impact sur le diagnostic moléculaire et la variabilité génétique intra-patient |
|
| Enjeux et pratiques de la recherche médicale transnationale en Afrique : analyse anthropologique d'un centre de recherche clinique sur le VIH à Dakar (Sénégal) |
|
| Epidemiological research applied to the fight against filariasis in Central Africa. |
|
| Epidémiologie du virus de l'immunodéficience simienne chez les gorilles : prévalence et transmission du SIVgor chez les gorilles en milieu naturel au Cameroun |
|
| Epidémiologie moléculaire, variabilité génétique et analyses phylogénétiques des virus de l'immunodéficience humaine au Congo-Brazzaville |
|
| Essai clinique randomisé, en double aveugle, évaluant la tolérance et l'efficacité de la moxidectine contrôlé par l'ivermectine chez des patients microfilarémiques à Loa loa |
|
| Etude clinique et moléculaire des pathologies infectieuses associées au Grand Magal de Touba |
|
| La gestion de la qualité des soins bucco-dentaires |
|
| Gorilla Gut Microbiota. |
|
| HBs Ag and antibodies to hepatitis C virus in complicated chronic liver disease in Gabon. A case control study |
|
| Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM) |
|
| Hepatitis C virus genotype 4 is highly prevalent in central Africa |
|
| High diversity of HIV-1 subtype F strains in Central Africa |
|
| High failure rate of the ViroSeq HIV-1 genotyping system for drug resistance testing in Cameroon, a country with broad HIV-1 genetic diversity |
|
| High HIV type 1 group M pol diversity and low rate of antiretroviral resistance mutations among the uniformed services in Kinshasa, Democratic Republic of the Congo |
|
| High prevalence of anti-hepatitis C virus antibodies in a Cameroon rural forest area |
|
| High prevalence of CRF02_AG and many minor resistance-related mutations at the protease gene among HIV-infected treatment-naive immigrants in Madrid |
|
| High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lomé, Togo |
|
| HIV-1 group O infection in Cameroon from 2006 to 2013: Prevalence, genetic diversity, evolution and public health challenges |
|
| HIV-1 subtypes and recombinants in the Republic of Congo |
|
| HIV Infection Does Not Explain Elevation of Glycated Hemoglobin among Non-Diabetic Patients in Gabon |
|
| HIV laboratory monitoring for effective ART in Africa – Authors' reply |
|
| HIV type-1 group O infection in Gabon: low prevalence rate but circulation of genetically diverse and drug-resistant HIV type-1 group O strains |
|
| HTLV-I Infection Among Prostitutes and Pregnant Women in Kinshasa, Zaïre |
|
| HTLV-II among pygmies from Cameroon. |
|
| Human T-cell leukemia virus type I isolates from Gabon and Ghana: comparative analysis of proviral genomes |
|
| Identification and molecular characterization of new simian T cell lymphotropic viruses in nonhuman primates bushmeat from the Democratic Republic of Congo |
|
| Identification of a new circulating recombinant form of HIV type 1, CRF11-cpx, involving subtypes A, G, J, and CRF01-AE, in Central Africa |
|
| Identification of all HIV type 1 group M subtypes in Senegal, a country with low and stable seroprevalence |
|
| Implementation and evaluation of a therapeutic patient education programme during a clinical trial in Yaoundé, Cameroon - Trial ANRS-12286/MOBIDIP. |
|
| In-depth analysis of HIV-1 drug resistance mutations in HIV-infected individuals failing first-line regimens in West and Central Africa |
|
| Incidence and determinants of new AIDS-defining illnesses after HAART initiation in a Senegalese cohort |
|
| Incidence of infectious morbidity events after second-line antiretroviral therapy initiation in HIV-infected adults in Yaoundé, Cameroon |
|
| Interpatient genetic variability of HIV-1 group O |
|
| Intestinal parasitic infections in HIV-infected patients, Lao People's Democratic Republic |
|
| Investigating the Circulation of Ebola Viruses in Bats during the Ebola Virus Disease Outbreaks in the Equateur and North Kivu Provinces of the Democratic Republic of Congo from 2018 |
|
| Investigation of minor species Candida africana, Candida stellatoidea and Candida dubliniensis in the Candida albicans complex among Yaoundé (Cameroon) HIV-infected patients |
|
| Is it necessary to conduct trials with trimethoprim-sulphamethoxazole amongst HIV-infected individuals in Africa? |
|
| Isolation and partial characterization of an HIV-related virus occurring naturally in chimpanzees in Gabon |
|
| Issue of HIV care treatement in Senegal. |
|
| De l'épidémiologie des HTLV-I ET HTLV-II dans des populations africaines ou d'origine africaine |
|
| De l'exception à la "normalisation" : Anthropologie de la santé reproductive confrontée au VIH au Sénégal |
|
| Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4- to 9-year antiretroviral therapy in Senegal: a case-control study. |
|
| Long-term impact of antiretroviral therapy in Africa: current knowledge |
|
| Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine |
|
| Low Levels of Antiretroviral‐Resistant HIV Infection in a Routine Clinic in Cameroon that Uses the World Health Organization (WHO) Public Health Approach to Monitor Antiretroviral Treatment and Adequacy with the WHO Recommendation for Second‐Line |
|
| Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Côte d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 study |
|
| Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy |
|
| Low rate of hepatitis C virus antibodies in blood donors and pregnant women from Niger |
|
| Microbiote intestinal des gorilles : évaluation de la diversité bactérienne, détection des pathogènes et description des nouvelles espèces |
|
| Molecular characterization of a novel simian immunodeficiency virus lineage (SIVtal) from northern talapoins (Miopithecus ogouensis). |
|
| Molecular characterization of the envelope transmembrane glycoprotein of 13 new human immunodeficiency virus type 1 group O strains from six different African countries |
|
| Molecular epidemiological tracing of HIV-1 outbreaks in Hainan island of southern China |
|
| Molecular epidemiology of simian immunodeficiency virus infection in wild-living gorillas |
|
| Molecular epidemiology reveals genetic diversity among 363 isolates of the Cryptococcus neoformans and Cryptococcus gattii species complex in 61 Ivorian HIV-positive patients |
|
| Molecular evidence for the presence of Rickettsia Felis in the feces of wild-living African apes |
|
| Molecular tracing of sexual HIV Type 1 transmission in the southwest border of China |
|
| Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial |
|
| Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study |
|
| Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG. |
|
| Mother-to-child transmission of human T-cell lymphotropic virus types I and II (HTLV-I/II) in Gabon: a prospective follow-up of 4 years |
|
| Multicentric cohort analysis of HIV programs supported by Médecins Sans Frontières France in sub-Saharan Africa. |
|
| Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study |
|
| Myéloradiculite bilharzienne : description et étude de trois cas importés |
|
| Prévalence et épidémiologie moléculaire du VIH-1 en Afrique centrale et de l'ouest : étude de cas en République Démocratique du Congo, au Nigeria et au Mali |
|
| Recherche de parasites intestinaux, communément associés à un stade d’immunodéficience chez l’Homme, dans des populations de grands singes sauvages infectés ou non par le virus de l’immunodéficience simienne (SIV) |
|
| Safety and short-term efficacy of a single dose of 2 mg moxidectin in Loa loa infected individuals : a double-blind, randomized ivermectin-controlled trial with ascending microfilarial densities. |
|
| SEROEPIDEMIOLOGIE DES INFECTIONS A VIH1 ET VIH2 AU GABON : OCTOBRE 85 - AVRIL 88 |
|
| A simple clinical and paraclinical score predictive of CD4 cells counts below 400/mm3 in HIV-infected adults in Dakar University Hospital, Senegal |
|
| Spécificités de l'infection par le Virus de l'Immunodéficience Humaine en Afrique subsaharienne et conséquences pour la prise en charge : à propos d'étude menées au Sénégal et au Cameroun entre 1996 et 2002 |
|
| Specificity of Human Immunodeficiency Virus infection in sub-Saharan Africa and consequenses for the management with regard to studies conducted in Senegal and Cameroon between 1996 and 2002. |
|
| Statistical modeling of the dynamics of Ebola virus infection in Guinea. |
|
| UNE STRATEGIE DE LUTTE CONTRE LE SIDA ET LES M.S.T. : LE DEPISTAGE DES M.S.T. A L'AIDE D'ALGORITHMES |
|
| Le VIH-2 infection orpheline ? : difficultés de prise en charge des enfants vivant avec le VIH-2 à Dakar, Sénégal |
|
| Virological response to ART in HIV-1 infected patients followed up in decentralized settings in West Africa (Senegal, Mali and Guinea Conakry). |
|
